A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers

Clinical trial NCT02583542 · UNKNOWN

Trial details

NCT number: NCT02583542
Sponsor: Queen Mary University of London
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple-Negative Breast Cancer Squamous Cell Lung Cancer Non-squamous Cell Lung Cancer With KRAS Mutations Non-squamous Cell Lung Cancer With Wild-type KRAS

Start date: 2015-06-01
Primary completion: 2020-03-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.